Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 79898-79899 [2015-32209]

Download as PDF 79898 Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices Architecture Program National Artist Registry, GSA Form 7437’’. Follow the instructions provided at the ‘‘Submit a Comment’’ screen. Please include your name, company name (if any), and ‘‘Information Collection 3090–0274, Artin-Architecture Program National Artist Registry, GSA Form 7437’’ on your attached document. • Mail: General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street, NW., Washington, DC 20405. ATTN: Ms. Flowers/IC 3090–0274, Art-inArchitecture Program National Artist Registry, GSA Form 7437. Instructions: Please submit comments only and cite Information Collection 3090–0274, Art-in-Architecture Program National Artist Registry, GSA Form 7437, in all correspondence related to this collection. Comments received generally will be posted without change to https://www.regulations.gov, including any personal and/or business confidential information provided. To confirm receipt of your comment(s), please check www.regulations.gov, approximately two to three days after submission to verify posting (except allow 30 days for posting of comments submitted by mail). SUPPLEMENTARY INFORMATION: A. Purpose The Art-in-Architecture Program actively seeks to commission works from the full spectrum of American artists and strives to promote new media and inventive solutions for public art. The GSA Form 7437, Art-inArchitecture Program National Artist Registry, will be used to collect information from artists across the country to participate and to be considered for commissions. tkelley on DSK3SPTVN1PROD with NOTICES B. Annual Reporting Burden Respondents: 300. Responses per Respondent: 1. Total Responses: .25. Hours per Response: .25. Total Burden Hours: 75. C. Public Comments Public comments are particularly invited on: Whether this collection of information is necessary and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate and based on valid assumptions and methodology; and ways to enhance the quality, utility, and clarity of the information to be collected. Obtaining Copies Of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, VerDate Sep<11>2014 18:05 Dec 22, 2015 Jkt 238001 Regulatory Secretariat (MVCB), 1800 F Street, NW., Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 3090– 0274, Art-in-Architecture Program National Artist Registry, GSA Form 7437, in all correspondence. Dated: December 17, 2015. David A. Shive, Chief Information Officer. [FR Doc. 2015–32202 Filed 12–22–15; 8:45 am] BILLING CODE 6820–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Times and Dates: 8:00 a.m.–5:00 p.m., EST, February 24, 2016 (Closed). 8:00 a.m.–5:00 p.m., EST, February 25, 2016 (Closed). Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: 703–684–5900, Fax: 703– 684–0653. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broad-based research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters for Discussion: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational healthrelated grant applications. PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Public Law 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, Ph.D., NIOSH Health Scientist, CDC, 2400 Executive Parkway, Mailstop E–20, Atlanta, Georgia 30345, Telephone: (404) 498–2511, Fax: (404) 498–2571. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office. Centers for Disease Control and Prevention. [FR Doc. 2015–32213 Filed 12–22–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP 16–001, Pregnancy Risk Assessment Monitoring System (PRAMS). Time and Date: 11:00 a.m.–6:00 p.m., EST, Panel D, February 4, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to E:\FR\FM\23DEN1.SGM 23DEN1 Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices ‘‘FOA DP16–001, Panel D, Pregnancy Risk Assessment Monitoring System (PRAMS)’’. Contact Person for More Information: Jayalakshmi Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488– 6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review tkelley on DSK3SPTVN1PROD with NOTICES Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–32210 Filed 12–22–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Board of Scientific Counselors, National Center for Health Statistics In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) announces the following meeting of the aforementioned committee. Times and Dates: 11:00 a.m.–5:30 p.m., EST, January 21, 2016. 8:30 a.m.–1:00 p.m., EST, January 22, 2016. Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782. Status: This meeting is open to the public; however, visitors must be processed in accordance with established federal policies and procedures. For foreign nationals or non-U.S. citizens, pre-approval is required (please contact Gwen Mustaf, 301–458–4500, glm4@cdc.gov, or Virginia Cain, vcain@cdc.gov at least 10 days in advance for requirements). All visitors are required to present a valid form of picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, Title 41, Code of Federal Regulation, Subpart 101–20.301, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. The meeting room accommodates approximately 100 people. Purpose: This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP 16–001, Pregnancy Risk Assessment Monitoring System (PRAMS). Time and Date: 12:00 p.m.–6:00 p.m., EST, Panel B, February 2, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘FOA DP16–001, Panel B, Pregnancy Risk Assessment Monitoring System (PRAMS)’’. Contact Person for More Information: Jayalakshmi Raman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Jkt 238001 [FR Doc. 2015–32208 Filed 12–22–15; 8:45 am] Centers for Disease Control and Prevention [FR Doc. 2015–32209 Filed 12–22–15; 8:45 am] 18:05 Dec 22, 2015 Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. VerDate Sep<11>2014 Georgia 30341, Telephone: (770) 488– 6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 79899 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP 16–001, Pregnancy Risk Assessment Monitoring System (PRAMS). Times and Dates: 10:00 a.m.–6:00 p.m., EST, Panel A1, January 20–21, 2016 (Closed). 10:00 a.m.–6:00 p.m., EST, Panel A2, January 27–28, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘FOA DP16–001, Panel A, Pregnancy Risk Assessment Monitoring System (PRAMS)’’. Contact Person for More Information: Jayalakshmi Raman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488– 6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Pages 79898-79899]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32209]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) DP 
16-001, Pregnancy Risk Assessment Monitoring System (PRAMS).
    Time and Date: 11:00 a.m.-6:00 p.m., EST, Panel D, February 4, 2016 
(Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to

[[Page 79899]]

``FOA DP16-001, Panel D, Pregnancy Risk Assessment Monitoring System 
(PRAMS)''.
    Contact Person for More Information: Jayalakshmi Raman Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, 
Atlanta, Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-32209 Filed 12-22-15; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.